Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients
Autor: | E. Vieira Neto, Lilian de Mattos Carvalho, Ida Vanessa Doederlein Schwartz, Ana Paula Vanz, Márcia Gonçalves Ribeiro, Claudia Braga Monteiro, Tássia Tonon, H.S. Maia Filho |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
Male
Parents Questionnaires Pediatrics Time Factors Physiology Phenylketonurias First year of life Fenilcetonuria Biochemistry 0302 clinical medicine Secondary Prevention Phenylketonuria Reference population General Pharmacology Toxicology and Pharmaceutics Child lcsh:QH301-705.5 Research Articles Intelligence Tests Metabolismo lcsh:R5-920 Intelligence quotient General Neuroscience Age Factors General Medicine humanities Pediatric patient Treatment Outcome Female Analysis of variance lcsh:Medicine (General) Brazil Quality of life medicine.medical_specialty congenital hereditary and neonatal diseases and abnormalities Adolescent Diet therapy Phenylalanine Immunology Biophysics 030209 endocrinology & metabolism Ocean Engineering 03 medical and health sciences medicine Humans Analysis of Variance business.industry Significant difference Patient compliance Cell Biology Fenilalanina Proxy Treatment Adherence and Compliance Socioeconomic Factors lcsh:Biology (General) Linear Models Self Report business 030217 neurology & neurosurgery |
Zdroj: | Repositório Institucional da UFRGS Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS Brazilian Journal of Medical and Biological Research, Vol 51, Iss 2 (2017) Brazilian Journal of Medical and Biological Research Brazilian Journal of Medical and Biological Research v.51 n.2 2018 Associação Brasileira de Divulgação Científica (ABDC) instacron:ABDC Brazilian Journal of Medical and Biological Research, Volume: 51, Issue: 2, Article number: e6709, Published: 11 DEC 2017 |
Popis: | Early dietary treatment of phenylketonuria (PKU), an inborn error of phenylalanine (Phe) metabolism, results in normal cognitive development. Although health-related quality of life (HRQoL) of PKU patients has been reported as unaffected in high-income countries, there are scarce data concerning HRQoL and adherence to treatment of PKU children and adolescents from Brazil. The present study compared HRQoL scores in core dimensions of Brazilian early-treated PKU pediatric patients with those of a reference population, and explored possible relationships between adherence to treatment and HRQoL. Early-treated PKU pediatric patient HRQoL was evaluated by self- and parent-proxy reports of the Pediatric Quality of Life Inventory (PedsQL) core scales. Adherence to treatment was evaluated by median Phe levels and percentage of results within the therapeutic target range in two periods. Means for total and core scales scores of PedsQL self- and parent proxy-reports of PKU patients were significantly lower than their respective means for controls. Adequacy of median Phe concentrations and the mean percentage of values in the target range fell substantially from the first year of life to the last year of this study. There was no significant difference in mean total and core scale scores for self- and parent proxy-reports between patients with adequate and those with inadequate median Phe concentrations. The harmful consequences for intellectual capacity caused by poor adherence to dietary treatment could explain the observed decrease in all HRQoL scales, especially in school functioning. Healthcare system and financial difficulties may also have influenced negatively all HRQoL dimensions. |
Databáze: | OpenAIRE |
Externí odkaz: |